Farrokh Alemi1, Mai Aljuaid2, Naren Durbha2, Melanie Yousefi3, Hua Min2, Louisa G Sylvia4,5, Andrew A Nierenberg4,5. 1. Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA. falemi@gmu.edu. 2. Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA. 3. School of Nursing, College of Health and Human Services, George Mason University, Fairfax, USA. 4. Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 5. Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: In real-world pragmatic administrative databases, patient reported remission is often missing. OBJECTIVE: We evaluate if, in administrative data, five features of antidepressant use patterns can replace patient-reported symptom remission. METHOD: We re-examined data from Sequence Treatment Alternatives to Relieve Depression (STAR*D) study. Remission was measured using 50% reduction in Hamilton index. Pattern of antidepressant use was examined through five variables: (a) number of prior ineffective antidepressants, (b) duration of taking current antidepressant, (c) receiving therapeutic dose of the medication, and (d) switching to another medication, or (e) augmenting with another antidepressant. The likelihood ratio (LR) associated with each of these predictors was assessed in 90% of data (3329 cases) and evaluated in 10% of data (350 cases) set-aside for evaluation. The accuracy of predictions was calculated using Area under the Receiver Operating Curve (AROC). RESULTS: Patients who took antidepressants for 14 weeks (LR = 2.007) were more likely to have symptom remission. Prior use of 3 antidepressants reduced the odds of remission (LR = 0.771). Patients who received antidepressants below therapeutic dose were 5 times less likely to experience remission (LR = 0.204). Antidepressant that were augment or switched, almost never led to remission (LR = 0.008, LR = 0.002 respectively). Patterns of antidepressant use accurately (AROC = 0.93) predicted symptom remission. CONCLUSION: Within the first 100 days, antidepressants use patterns could serve as a surrogate measure for patient-reported remission of symptoms.
BACKGROUND: In real-world pragmatic administrative databases, patient reported remission is often missing. OBJECTIVE: We evaluate if, in administrative data, five features of antidepressant use patterns can replace patient-reported symptom remission. METHOD: We re-examined data from Sequence Treatment Alternatives to Relieve Depression (STAR*D) study. Remission was measured using 50% reduction in Hamilton index. Pattern of antidepressant use was examined through five variables: (a) number of prior ineffective antidepressants, (b) duration of taking current antidepressant, (c) receiving therapeutic dose of the medication, and (d) switching to another medication, or (e) augmenting with another antidepressant. The likelihood ratio (LR) associated with each of these predictors was assessed in 90% of data (3329 cases) and evaluated in 10% of data (350 cases) set-aside for evaluation. The accuracy of predictions was calculated using Area under the Receiver Operating Curve (AROC). RESULTS:Patients who took antidepressants for 14 weeks (LR = 2.007) were more likely to have symptom remission. Prior use of 3 antidepressants reduced the odds of remission (LR = 0.771). Patients who received antidepressants below therapeutic dose were 5 times less likely to experience remission (LR = 0.204). Antidepressant that were augment or switched, almost never led to remission (LR = 0.008, LR = 0.002 respectively). Patterns of antidepressant use accurately (AROC = 0.93) predicted symptom remission. CONCLUSION: Within the first 100 days, antidepressants use patterns could serve as a surrogate measure for patient-reported remission of symptoms.
Authors: Floor Holvast; Bernard A van Hattem; Judith Sinnige; François Schellevis; Katja Taxis; Huibert Burger; Peter F M Verhaak Journal: Fam Pract Date: 2017-09-01 Impact factor: 2.267
Authors: Roy H Perlis; Michael J Ostacher; Jayendra K Patel; Lauren B Marangell; Hongwei Zhang; Stephen R Wisniewski; Terence A Ketter; David J Miklowitz; Michael W Otto; Laszlo Gyulai; Noreen A Reilly-Harrington; Andrew A Nierenberg; Gary S Sachs; Michael E Thase Journal: Am J Psychiatry Date: 2006-02 Impact factor: 18.112
Authors: A John Rush; M Lynn Crismon; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; Madhukar H Trivedi; Trisha Suppes; Alexander L Miller; Melanie M Biggs; Kathy Shores-Wilson; Bradley P Witte; Steven P Shon; William V Rago; Kenneth Z Altshuler Journal: J Clin Psychiatry Date: 2003-04 Impact factor: 4.384
Authors: Madhukar H Trivedi; A John Rush; M Lynn Crismon; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; Tracie Key; Melanie M Biggs; Kathy Shores-Wilson; Bradley Witte; Trisha Suppes; Alexander L Miller; Kenneth Z Altshuler; Steven P Shon Journal: Arch Gen Psychiatry Date: 2004-07
Authors: A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe Journal: Control Clin Trials Date: 2004-02
Authors: Farrokh Alemi; Hua Min; Melanie Yousefi; Laura K Becker; Christopher A Hane; Vijay S Nori; Janusz Wojtusiak Journal: EClinicalMedicine Date: 2021-10-25